Denali Advisors LLC Has $2.20 Million Stake in Ardent Health, Inc. $ARDT

Denali Advisors LLC boosted its position in Ardent Health, Inc. (NYSE:ARDT) by 35.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 249,450 shares of the company’s stock after buying an additional 64,650 shares during the period. Denali Advisors LLC’s holdings in Ardent Health were worth $2,203,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Ameriprise Financial Inc. increased its stake in Ardent Health by 8.2% in the third quarter. Ameriprise Financial Inc. now owns 1,769,335 shares of the company’s stock valued at $23,444,000 after purchasing an additional 134,513 shares in the last quarter. Vanguard Group Inc. increased its stake in Ardent Health by 44.5% in the third quarter. Vanguard Group Inc. now owns 1,352,676 shares of the company’s stock valued at $17,923,000 after purchasing an additional 416,348 shares in the last quarter. Millennium Management LLC increased its stake in Ardent Health by 6.6% in the third quarter. Millennium Management LLC now owns 1,269,605 shares of the company’s stock valued at $16,822,000 after purchasing an additional 78,861 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company’s stock valued at $10,558,000 after purchasing an additional 724,841 shares in the last quarter. Finally, Pier Capital LLC increased its stake in Ardent Health by 33.5% in the third quarter. Pier Capital LLC now owns 580,620 shares of the company’s stock valued at $7,693,000 after purchasing an additional 145,703 shares in the last quarter.

Ardent Health Stock Up 2.3%

ARDT opened at $10.13 on Friday. The stock has a market cap of $1.45 billion, a price-to-earnings ratio of 10.66, a PEG ratio of 2.20 and a beta of 0.93. The company has a quick ratio of 1.85, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. The company’s 50-day moving average price is $9.26 and its two-hundred day moving average price is $9.75. Ardent Health, Inc. has a twelve month low of $8.07 and a twelve month high of $15.48.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The company had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, equities analysts expect that Ardent Health, Inc. will post 1.12 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on ARDT shares. Royal Bank Of Canada decreased their price target on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, March 9th. Leerink Partners decreased their price target on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research note on Friday, March 6th. JPMorgan Chase & Co. decreased their target price on shares of Ardent Health from $12.00 to $11.00 and set a “neutral” rating for the company in a research report on Tuesday, January 20th. UBS Group boosted their target price on shares of Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday. Finally, Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Seven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $14.21.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.